Winter 2021 (Volume 31, Number 4)
Survey Results: CIORA
Download PDF
The Canadian Initiative for Outcomes in Rheumatology
cAre (CIORA) is a unique granting division of the
CRA committed to being a catalyst for improving the
care of Canadians living with all rheumatic diseases.
For this issue’s Joint Count, the CRA surveyed its
members regarding their perspectives on CIORA, its
structure, and potential areas of focus to reflect the current
gaps and needs in rheumatology in Canada. A total of
93 responses were received, equating to a response rate of
17% (97/578).
As it currently stands, CIORA’s grant program supports
sustainable projects related to rheumatic diseases that
promote the following (also known as pillars): (1) awareness/advocacy/education (health economics/sustainability
of health care/quality improvement); (2) early access
for rheumatic disease patients; (3) multi-disciplinary care
teams; and more recently (4) community rheumatology.
When asked if they would be in favour of removing the
CIORA pillars and simply promoting excellence in clinical
research, 82% of respondents were in favor of removing the
pillars (see Chart 1). One member commented that CIORA
has become a major funder of rheumatology research, so
the focus should be on excellence. Another said, “I say yes,
but I think the question is why were the pillars established
to begin with (e.g. was it to fill a gap or promote research
areas that were less represented but felt to be important)?
It's hard to answer this question without understanding
the background of the pillars.”
Members were also asked whether CIORA should have
research grants in priority areas (e.g., cannabis research,
COVID, Indigenous health, etc.). Half of the survey-takers
said no, while 21% said yes and 29% were unsure
(see Chart 2). Those who responded affirmatively suggested
priority topics such as pediatrics; pregnancy and
rheumatic disease; treatment interventions and effects on
function/daily life; research focused on marginalized or
under-served populations (e.g., Indigenous communities,
recent immigrants, transgender persons); equity, diversity,
and inclusion; COVID-19;and telemedicine.
Most respondents (75%) confirmed that they are aware
that all CRA members including community rheumatologists
can apply for a CIORA grant, that there are reserved
funds for grants to community rheumatologists, and that
there is support available on how to write a grant. Approximately,
37% of survey-takers said that they had already submitted
a CIORA grant. Those who hadn’t submitted a grant
stated that they had not done so due to time constraints or
that research wasn’t a priority focus for them at the present
time; a few explained that they were still in the early
stages of their careers, and others said that they would be
interested in submitting in the future.
For any questions or feedback regarding CIORA, write
to Virginia Hopkins at vhopkins@rheum.ca, and to find out
more about CIORA, visit rheum.ca/ciora/.
|